Vitiligo - Part 1
Explore this paper's citation graph
Summary
The autoimmune hypothesis is now the most cited and studied among experts, and Dysfunction in metabolic pathways, which could lead to production of toxic metabolites causing damage to melanocytes, has also been investigated.
- Type
- review
- Published
- 2014-05-01
- Cited by
- 59
- References
- 149
- Access
- Open access
- OpenAlex
- https://openalex.org/W1967187858
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:265804667
Keywords
Vitiligo, Context (archaeology), Disease, Pathogenesis, Biology
References
- British Photodermatology Group guidelines for PUVA.
- Vitiligo prevalence study in Shaanxi Province, China
- Association of catalase T/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population.
- PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
- Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions
- Cellular and developmental aspects of androgenetic alopecia
- Hypoacusis in vitiligo.
- The PTPN22‐1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population
- Genetic epidemiology of vitiligo: multilocus recessivity cross-validated.
- Reduced skin homing by functional Treg in vitiligo
- Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo
- Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners
- First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi
- Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
- Autoimmune etiology of generalized vitiligo.
- Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells
- Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo.
- Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo.
- Comparisons of clinical features of HLA‐DRB1*07 positive and negative vitiligo patients in Chinese Han population
- The prevalence of thyroid disease in patients with vitiligo: a systematic review
Cited by
- Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese*
- Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin.
- Progression of Cutaneous Vitiligo in a Patient with Large Posterior Choroidal Melanoma: A Case Report
- Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo
- Resident T cells in human skin : functional heterogeneity and clinical implications
- The Epidemiology and Treatment of Vitiligo: A Chinese Perspective
- Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review
- Evaluation of the Clinical and Sociodemographic Features of Turkish Patients with Vitiligo.
- A Practical Approach to the Diagnosis and Treatment of Vitiligo in Children
- Pigmentation Disorders: A Short Review
- Knowledge, beliefs, and perceptions of Turkish vitiligo patients regarding their condition
- Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets
- Association of protein tyrosine phosphatase, non-receptor type 22 +1858C→T polymorphism and susceptibility to vitiligo: Systematic review and meta-analysis
- Impact of Vitiligo on Quality of Life.
- Cutaneous Field Cancerization on a Vitiligo Area
- Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo
- Insight into Natural History of Congenital Vitiligo: A Case Report of a 23-Year-Old with Stable Congenital Vitiligo
- A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
- Prevalence of vitiligo in Brazil—A population survey
- Cytokine profile (IL‐2, IL‐6, IL‐17, IL‐22, and TNF‐α) in vitiligo—New insight into pathogenesis of disease
Related papers
- 26957 A study of dermoscopic features in relation to vitiligo activity
- Prevalence of vitiligo among type 2 diabetic patients in an Iranian population
- VITILIGO IN MATURE‐ONSET DIABETES MELLITUS
- A Case of Vitiligo Repigmented with Topical Tacrolimus
- Hyperpigmentation in photo exposed patches of vitiligo following tacrolimus therapy
- Treatment of vitiligo with topical PUVA
- Vitiligo Lesions Improved after Oral Cyclosporine in a Patient with Vitiligo and Atopic Dermatitis
- Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream
- Actinic keratoses arising only on sun‐exposed vitiligo skin
- Dermatitis produced by applications of monobenzone in patients with active vitiligo.